DISTRIBUTION OF COMPLEMENT REGULATORS (CD46, CD55 AND CD59) IN SKIN APPENDAGES, AND IN BENIGN AND MALIGNANT SKIN NEOPLASMS

被引:25
作者
SAYAMA, K
SHIRAISHI, S
MIKI, Y
机构
[1] Department of Dermatology., Ehime University School of Medicine, Ehime, Shigenobucho
关键词
D O I
10.1111/j.1365-2133.1992.tb14814.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Immunohistochemical studies were performed to establish the distribution of membrane cofactor protein (MCP; CD46), decay-accelerating (DAF; CD55) and homologous restriction factor (HRF20; CD59), in normal skin appendages, and in benign and malignant skin neoplasms. At least two of these regulators were detected on normal eccrine glands, apocrine glands and sebaceous glands. They were also found in cellular naevi (CN), seborrhoeic keratoses (SK), basal cell carcinoma (BCC), Bowen's disease (BD), squamous cell carcinoma (SCC) and Paget's disease (PD). Although there were slight differences in their distribution, these regulators were found in all the cells examined, indicating that they are essential factors in human skin as well as other organs, and in neoplasms, in preventing autologous complement attack.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 19 条
[1]   DECAY-ACCELERATING FACTOR PROTECTS HUMAN-TUMOR CELLS FROM COMPLEMENT-MEDIATED CYTO-TOXICITY INVITRO [J].
CHEUNG, NKV ;
WALTER, EI ;
SMITHMENSAH, WH ;
RATNOFF, WD ;
TYKOCINSKI, ML ;
MEDOF, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) :1122-1128
[2]   DISTRIBUTION OF DECAY-ACCELERATING FACTOR IN THE PERIPHERAL-BLOOD OF NORMAL INDIVIDUALS AND PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].
KINOSHITA, T ;
MEDOF, ME ;
SILBER, R ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :75-92
[3]   IDENTIFICATION OF THE COMPLEMENT DECAY-ACCELERATING FACTOR (DAF) ON EPITHELIUM AND GLANDULAR CELLS AND IN BODY-FLUIDS [J].
MEDOF, ME ;
WALTER, EI ;
RUTGERS, JL ;
KNOWLES, DM ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :848-864
[4]  
NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184
[5]   COMPLEMENT ALLOTYPES IN JAPANESE PATIENTS WITH PEMPHIGUS AND BULLOUS PEMPHIGOID [J].
NISHIMUKAI, H ;
SHIRAISHI, S ;
SHIRAKATA, Y ;
SAYAMA, K ;
SHINOMIYA, T ;
MIKI, Y .
DERMATOLOGICA, 1991, 182 (03) :164-167
[6]  
NOSE M, 1990, IMMUNOLOGY, V70, P145
[7]  
OKADA N, 1989, J IMMUNOL, V143, P2262
[8]  
Sayama K, 1988, Trans Assoc Am Physicians, V101, P270
[9]   COMPLEMENT PROFILE IN A CI INHIBITOR DEFICIENT FAMILY [J].
SAYAMA, K ;
SHIRAISHI, S ;
MIKI, Y .
BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 (06) :737-743
[10]   CHARACTERIZATION OF DECAY-ACCELERATING FACTOR (DAF) IN HUMAN SKIN [J].
SAYAMA, K ;
SHIRAISHI, S ;
SHIRAKATA, Y ;
KOBAYASHI, Y ;
MIKI, Y .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (01) :61-64